ICU Medical, Inc. NASDAQ:ICUI

ICU Medical stock price today

$123.76
-30.70
-19.88%
Financial Health
0
1
2
3
4
5
6
7
8
9

ICU Medical stock price monthly change

+22.61%
month

ICU Medical stock price quarterly change

+22.61%
quarter

ICU Medical stock price yearly change

+54.99%
year

ICU Medical key metrics

Market Cap
3.74B
Enterprise value
5.73B
P/E
-55.83
EV/Sales
2.51
EV/EBITDA
30.62
Price/Sales
1.84
Price/Book
2.01
PEG ratio
0.23
EPS
-2.45
Revenue
2.25B
EBITDA
241.12M
Income
-59.31M
Revenue Q/Q
-0.47%
Revenue Y/Y
-2.12%
Profit margin
-3.26%
Oper. margin
-0.16%
Gross margin
30.6%
EBIT margin
-0.16%
EBITDA margin
10.69%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

ICU Medical stock price history

ICU Medical stock forecast

ICU Medical financial statements

Average Price Target
Last Year

$190.5

Potential upside: 53.92%

Based on estimate of 2 analysts
  • Analysts Price target

  • Financials & Ratios estimates

ICU Medical, Inc. (NASDAQ:ICUI): Profit margin
Jun 2023 549.31M -9.93M -1.81%
Sep 2023 553.31M 7.23M 1.31%
Dec 2023 587.98M -17.14M -2.92%
Mar 2024 565.95M -39.47M -6.97%
ICU Medical, Inc. (NASDAQ:ICUI): Debt to assets
Jun 2023 4463044000 2.34B 52.61%
Sep 2023 4376864000 2.27B 52.06%
Dec 2023 4378439000 2.25B 51.5%
Mar 2024 4288398000 2.22B 51.78%
ICU Medical, Inc. (NASDAQ:ICUI): Cash Flow
Jun 2023 -1.47M -17.60M -5.89M
Sep 2023 35.16M -24.50M -6.39M
Dec 2023 91.26M -30.65M -7.84M
Mar 2024 45.79M -17.86M -26.84M

ICU Medical alternative data

ICU Medical, Inc. (NASDAQ:ICUI): Employee count
Aug 2023 14,500
Sep 2023 14,500
Oct 2023 14,500
Nov 2023 14,500
Dec 2023 14,500
Jan 2024 14,500
Feb 2024 14,500
Mar 2024 14,000
Apr 2024 14,000
May 2024 14,000
Jun 2024 14,000
Jul 2024 14,000

ICU Medical other data

89.46% -1.17%
of ICUI is owned by hedge funds
21.37M -52.44K
shares is hold by hedge funds

ICU Medical, Inc. (NASDAQ:ICUI): Insider trades (number of shares)
Period Buy Sel
Feb 2024 0 1660000
Mar 2024 0 71983
May 2024 0 14839
Aug 2024 0 16552
Sep 2024 0 12000
Oct 2024 0 12000
Nov 2024 0 24083
Dec 2024 0 14241
Transaction Date Insider Security Shares Price per share Total value Source
Sale
WOOLSON DANIEL officer: VP, GM-Infusion Capital
Common Stock 2,241 $156.25 $350,158
Option
JAIN VIVEK director, officer.. Common Stock 12,000 $88.76 $1,065,120
Sale
JAIN VIVEK director, officer.. Common Stock 3,672 $162.29 $595,922
Sale
JAIN VIVEK director, officer.. Common Stock 8,250 $163.18 $1,346,227
Sale
JAIN VIVEK director, officer.. Common Stock 78 $163.96 $12,789
Option
JAIN VIVEK director, officer.. Non-Qualified Stock Option (right to buy) 12,000 $88.76 $1,065,120
Option
GREENBERG DAVID C. director
Common Stock 972 $94.68 $92,029
Sale
GREENBERG DAVID C. director
Common Stock 972 $158.11 $153,683
Option
GREENBERG DAVID C. director
Non-Qualified Stock Option (right to buy) 972 $94.68 $92,029
Option
VOIGTLANDER CHRISTIAN B. officer: Chief Op.. Non-Qualified Stock Option (right to buy) 1,430 $96.83 $138,467
Patent
Grant
Filling date: 29 May 2020 Issue date: 13 Sep 2022
Grant
Filling date: 28 May 2019 Issue date: 13 Sep 2022
Grant
Filling date: 22 Jun 2020 Issue date: 6 Sep 2022
Grant
Filling date: 21 Nov 2019 Issue date: 6 Sep 2022
Grant
Filling date: 27 Dec 2018 Issue date: 6 Sep 2022
Application
Filling date: 17 Feb 2022 Issue date: 25 Aug 2022
Grant
Filling date: 28 Aug 2019 Issue date: 2 Aug 2022
Grant
Filling date: 27 Apr 2020 Issue date: 26 Jul 2022
Application
Filling date: 31 Mar 2022 Issue date: 21 Jul 2022
Grant
Filling date: 21 Dec 2017 Issue date: 19 Jul 2022
Tuesday, 12 November 2024
seekingalpha.com
zacks.com
prnewswire.com
Wednesday, 6 November 2024
globenewswire.com
Monday, 28 October 2024
zacks.com
globenewswire.com
Friday, 18 October 2024
zacks.com
Wednesday, 25 September 2024
zacks.com
Tuesday, 17 September 2024
zacks.com
Friday, 23 August 2024
zacks.com
Thursday, 22 August 2024
zacks.com
Wednesday, 21 August 2024
globenewswire.com
Wednesday, 7 August 2024
seekingalpha.com
zacks.com
Monday, 20 May 2024
https://www.defenseworld.net
Tuesday, 7 May 2024
Seeking Alpha
Zacks Investment Research
Tuesday, 23 April 2024
GlobeNewsWire
Wednesday, 13 March 2024
GlobeNewsWire
Friday, 1 March 2024
GlobeNewsWire
Tuesday, 27 February 2024
Zacks Investment Research
Zacks Investment Research
Tuesday, 13 February 2024
GlobeNewsWire
Wednesday, 8 November 2023
Seeking Alpha
Monday, 6 November 2023
Seeking Alpha
Monday, 23 October 2023
GlobeNewsWire
Monday, 4 September 2023
Zacks Investment Research
Monday, 21 August 2023
Seeking Alpha
Monday, 7 August 2023
Zacks Investment Research
Monday, 24 July 2023
GlobeNewsWire
  • What's the price of ICU Medical stock today?

    One share of ICU Medical stock can currently be purchased for approximately $123.76.

  • When is ICU Medical's next earnings date?

    Unfortunately, ICU Medical's (ICUI) next earnings date is currently unknown.

  • Does ICU Medical pay dividends?

    No, ICU Medical does not pay dividends.

  • How much money does ICU Medical make?

    ICU Medical has a market capitalization of 3.74B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.92% to 2.26B US dollars.

  • What is ICU Medical's stock symbol?

    ICU Medical, Inc. is traded on the NASDAQ under the ticker symbol "ICUI".

  • What is ICU Medical's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of ICU Medical?

    Shares of ICU Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are ICU Medical's key executives?

    ICU Medical's management team includes the following people:

    • Mr. Vivek Jain Chief Executive Officer & Chairman(age: 53, pay: $1,310,000)
    • Mr. Brian Michael Bonnell Chief Financial Officer & Treasurer(age: 51, pay: $726,990)
    • Mr. Christian B. Voigtlander Chief Operating Officer(age: 56, pay: $684,830)
    • Ms. Virginia Ruth Sanzone Corporation Vice President, Gen. Counsel, Sec. & Compliance Officer(age: 50, pay: $492,820)
  • How many employees does ICU Medical have?

    As Jul 2024, ICU Medical employs 14,000 workers.

  • When ICU Medical went public?

    ICU Medical, Inc. is publicly traded company for more then 33 years since IPO on 31 Mar 1992.

  • What is ICU Medical's official website?

    The official website for ICU Medical is icumed.com.

  • Where are ICU Medical's headquarters?

    ICU Medical is headquartered at 951 Calle Amanecer, San Clemente, CA.

  • How can i contact ICU Medical?

    ICU Medical's mailing address is 951 Calle Amanecer, San Clemente, CA and company can be reached via phone at +94 93662183.

  • What is ICU Medical stock forecast & price target?

    Based on 2 Wall Street analysts` predicted price targets for ICU Medical in the last 12 months, the avarage price target is $190.5. The average price target represents a 53.92% change from the last price of $123.76.

ICU Medical company profile:

ICU Medical, Inc.

icumed.com
Exchange:

NASDAQ

Full time employees:

14,000

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

951 Calle Amanecer
San Clemente, CA 92673

CIK: 0000883984
ISIN: US44930G1076
CUSIP: 44930G107